Shin-ichiro Imai

Title: Innovations of Shin-ichiro Imai

Introduction

Shin-ichiro Imai is a prominent inventor based in Saint Louis, MO (US). He has made significant contributions to the field of medical research, particularly in the treatment of age-related diseases. With a total of three patents to his name, Imai's work focuses on innovative methods to improve health outcomes.

Latest Patents

Imai's latest patents revolve around the administration of nicotinamide mononucleotide (NMN) in the treatment of various diseases. These patents disclose methods and compositions aimed at treating, ameliorating, mitigating, slowing, arresting, preventing, or reversing conditions such as age-related obesity, increases in blood lipid levels, decreases in insulin sensitivity, memory function decline, and changes in eye function, including macular degeneration. The methods involve administering NMN to a subject, with some embodiments allowing for oral administration. Additionally, pharmaceutical compositions comprising NMN are also disclosed.

Career Highlights

Shin-ichiro Imai is affiliated with Washington University, where he conducts his research and develops his innovative solutions. His work has garnered attention for its potential to address significant health challenges associated with aging.

Collaborations

Imai collaborates with various professionals in his field, including Rajendra S Apte, to enhance the impact of his research and innovations.

Conclusion

Shin-ichiro Imai's contributions to the field of medical research through his patents on NMN administration highlight his commitment to improving health outcomes for aging populations. His work continues to pave the way for advancements in the treatment of age-related diseases.